Cedars Sinai
VC Fund
Los Angeles, United States
Cedars Sinai is a VC fund in Los Angeles focused on Health Care and Medical. Cedars-Sinai is a non-profit, academic, community-centric medical center in Los Angeles, California. Recognized internationally, Cedars-Sinai brings together top healthcare professionals collaborating to provide exceptional patient care.
- Total investments:
- 35
- Last investment:
- Lead investor:
- 34%
Last updated:
For AI agents: llms.txt
Industries Cedars Sinai invests in
Stages Cedars Sinai invests in
Countries Cedars Sinai invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Arthur Ochoa
|
|||
David Wrigley
|
|||
Michael Alexander
|
|||
Michael Langberg
|
|||
Raj Khandwalla
|
Investment Focus
Industry
- Health Care 17 (49%)
- Medical 11 (31%)
- Software 8 (23%)
- Artificial Intelligence 8 (23%)
- Biotechnology 7 (20%)
Stage
- Seed 10 (29%)
- Series A 7 (20%)
- Series B 3 (9%)
- Funding Round 3 (9%)
- Venture - Series Unknown 3 (9%)
Country
- United States 19 (54%)
- United Kingdom 5 (14%)
- The Netherlands 2 (6%)
- India 1 (3%)
- Canada 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Arthur Ochoa
SVP, Advancement & CAO
|
SVP, Advancement & CAO | Total investments: 0 | Find email | |
|
David Wrigley
CFO & Senior Vice President Finance
|
CFO & Senior Vice President Finance | Total investments: 0 | Find email | |
|
Michael Alexander
Professor and Vice-Chairman
|
Professor and Vice-Chairman | Total investments: 0 | Find email | |
|
Michael Langberg
Senior Vice President of Medical Affairs & Chief Medical Officer
|
Senior Vice President of Medical Affairs & Chief Medical Officer | Total investments: 0 | Find email | |
|
Raj Khandwalla
Assistant Professor of Medicine
|
Assistant Professor of Medicine | Total investments: 0 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Klaris
|
Klaris automates the manual work medical device companies waste on regulatory documentation. Our first product is an AI Auditor with superhuman abilities. | $1M / Pre-Seed / Feb 17, 2026 | |
Mitera Biosciences
|
Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights. | $1.8M / Seed / Dec 30, 2025 | |
OnboardAI
|
Onboard AI is a software company specializing in AI governance and compliance tools for healthcare organizations. | $5M / Seed / Nov 20, 2025 | |
Neolook
|
Neolook Solutions B.V. is a Netherlands-based MedTech company founded in 2020 as an independent spin-out from Royal Philips, with roots in a 2016-2017 clinical proof-of-concept at Fatebenefratelli Hospital in Rome. The company specialises in medical-grade livestream and datastream applications for neonatal (NICU) and paediatric intensive care(PICU), serving three core stakeholder groups: families, clinical practitioners, and researchers. The S2S Platform - comprising S2S Family, S2S Professional, and S2S Academic - enables secure high-resolution video and data connectivity across the full care continuum, from bedside to home. The EarlyMoves product line adds AI-ready remote General Movement Assessment for early detection of neurological disorders in high-risk infants. Neolook has achieved CE MDR Class I certification, ISO 27001, and NEN 7510 compliance. The company has been designated a national NICU facility in the Netherlands at the request of Dutch health insurers, validating significant institutional demand. | $608.7K / Seed / Nov 01, 2025 | |
Kneu Health
|
Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia. | $5.6M / Seed / Oct 09, 2025 | |
Visby Medical
|
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools thatare both highly accurate and delightful to use. | $55M / Venture - Series Unknown / Jun 17, 2025 | |
Paperplane Therapeutics
|
Paperplane Therapeutics is a software company that designs therapeutic virtual reality video games for children suffering from anxiety. | $1.5M / Seed / Feb 18, 2025 | |
Neu Health
|
Neu Health enables clinicians, caregivers, and patients to tackle this growing challenge with cutting-edge digital technologies. | $2M / Seed / Jan 29, 2025 | |
|
Neu Health
|
Neu Health enables clinicians, caregivers, and patients to tackle this growing challenge with cutting-edge digital technologies. | $2M / Seed / Jan 29, 2025 | |
52 North Health
|
52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy. | $6M / Dec 03, 2024 | |
| See all 35 investments → | |||
Co-Investors
Pitango VC
4 deals together
Lightspeed Venture Partners
3 deals together
+ND Capital
3 deals together
Oxford Science Enterprises
3 deals together
Artiman Ventures
2 deals together
Blue Water Life Science Advisors
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cedars Sinai invest in?
Cedars Sinai invests primarily in Health Care, Medical and Software startups, most often at Seed and Series A stage. Most of the 35 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cedars Sinai?
Public channels for Cedars Sinai include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cedars Sinai?
The team at Cedars Sinai includes Arthur Ochoa (SVP, Advancement & CAO), David Wrigley (CFO & Senior Vice President Finance) and Michael Alexander (Professor and Vice-Chairman), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
